These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26424521)

  • 21. CXC receptor 1 and 2 and neutrophil elastase inhibitors alter radiation-induced lung disease in the mouse.
    Fox J; Haston CK
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):215-22. PubMed ID: 22929857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemotactic activity of sputum from patients with bronchiectasis.
    Mikami M; Llewellyn-Jones CG; Bayley D; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):723-8. PubMed ID: 9517582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
    Virtala R; Ekman AK; Jansson L; Westin U; Cardell LO
    Clin Exp Allergy; 2012 Apr; 42(4):590-6. PubMed ID: 22192144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of WO2012080456 and WO2012080457; Boheringer Ingleheim's first CXCR2 antagonists.
    Norman P
    Expert Opin Ther Pat; 2013 Mar; 23(3):383-8. PubMed ID: 23321068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.
    Daviskas E; Anderson SD; Young IH
    Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.
    Holz O; Khalilieh S; Ludwig-Sengpiel A; Watz H; Stryszak P; Soni P; Tsai M; Sadeh J; Magnussen H
    Eur Respir J; 2010 Mar; 35(3):564-70. PubMed ID: 19643947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
    Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
    J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral administration of AZD8309, a CXCR2 antagonist, on the severity of experimental pancreatitis.
    Malla SR; Kärrman Mårdh C; Günther A; Mahajan UM; Sendler M; D'Haese J; Weiss FU; Lerch MM; Hansen MB; Mayerle J
    Pancreatology; 2016; 16(5):761-9. PubMed ID: 27450968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer.
    Beeh KM; Beier J; Ernst M; Kornmann O; Buhl R
    Respiration; 2003; 70(2):166-71. PubMed ID: 12740514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
    Barker AF; O'Donnell AE; Flume P; Thompson PJ; Ruzi JD; de Gracia J; Boersma WG; De Soyza A; Shao L; Zhang J; Haas L; Lewis SA; Leitzinger S; Montgomery AB; McKevitt MT; Gossage D; Quittner AL; O'Riordan TG
    Lancet Respir Med; 2014 Sep; 2(9):738-49. PubMed ID: 25154045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation: a two-edged sword--the model of bronchiectasis.
    Cole PJ
    Eur J Respir Dis Suppl; 1986; 147():6-15. PubMed ID: 3533593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Elementary therapeutical prescriptions for bronchiectasis].
    Cairella M
    Clin Ter; 1968 Mar; 44(5):463-7. PubMed ID: 5739595
    [No Abstract]   [Full Text] [Related]  

  • 35. Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite.
    Hickey MJ; Allen PH; Caffrey M; Hansen P; Kingston LP; Wilkinson DJ
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):432-8. PubMed ID: 27461061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
    Wills PJ; Wodehouse T; Corkery K; Mallon K; Wilson R; Cole PJ
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum zinc, bronchiectasis, and bronchial carcinoma.
    Beeley JM; Darke CS; Owen G COOPER RD
    Thorax; 1974 Jan; 29(1):21-5. PubMed ID: 4596632
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
    Gjoerup J; Hilberg O; Bendstrup E
    Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
    Rennard SI; Dale DC; Donohue JF; Kanniess F; Magnussen H; Sutherland ER; Watz H; Lu S; Stryszak P; Rosenberg E; Staudinger H
    Am J Respir Crit Care Med; 2015 May; 191(9):1001-11. PubMed ID: 25695403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.